+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Gonorrhea Drug"

Gonorrhea Therapeutics Market 2024-2028 - Product Thumbnail Image

Gonorrhea Therapeutics Market 2024-2028

  • Report
  • May 2024
  • 170 Pages
  • Global
From
Gonorrhea (GN): Competitive Landscape - Product Thumbnail Image

Gonorrhea (GN): Competitive Landscape

  • Report
  • September 2024
  • 78 Pages
  • Global
From
From
From
From
From
Gonorrhea - Epidemiology Forecast - 2032 - Product Thumbnail Image

Gonorrhea - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Gonorrhea Treatment Market Report and Forecast 2023-2031 - Product Thumbnail Image

Gonorrhea Treatment Market Report and Forecast 2023-2031

  • Report
  • March 2023
  • 147 Pages
  • Global
From
From
From
From
  • 12 Results (Page 1 of 1)
Loading Indicator

The Gonorrhea Drug market is a subset of the Infectious Diseases Drugs market, which includes drugs used to treat a variety of bacterial, viral, and fungal infections. Gonorrhea is a sexually transmitted infection caused by the bacterium Neisseria gonorrhoeae. Treatment for gonorrhea typically involves antibiotics, such as cephalosporins, macrolides, and fluoroquinolones. These drugs are used to reduce the symptoms of the infection and prevent further spread. The market for Gonorrhea Drugs is highly competitive, with a number of major pharmaceutical companies offering products. These companies include Pfizer, Merck, GlaxoSmithKline, Sanofi, AstraZeneca, and Bayer. Additionally, there are a number of smaller companies that specialize in the development and manufacture of Gonorrhea Drugs. Show Less Read more